Literature DB >> 32335299

Research progress in use of traditional Chinese medicine for treatment of spinal cord injury.

Yubao Lu1, Jingjing Yang1, Xuexi Wang2, Zhanjun Ma3, Sheng Li4, Zhaoyang Liu5, Xuegong Fan6.   

Abstract

BACKGROUND: Spinal cord injury (SCI) is a serious central nervous system disorder caused by trauma that has gradually become a major challenge in clinical medical research. As an important branch of worldwide medical research, traditional Chinese medicine (TCM) is rapidly moving towards a path of reform and innovation. Therefore, this paper systematically reviews research related to existing TCM treatments for SCI, with the aims of identifying deficits and shortcomings within the field, and proposing feasible alternative prospects.
METHODS: All data and conclusions in this paper were obtained from articles published by peers in relevant fields. PubMed, SciFinder, Google Scholar, Web of Science, and CNKI databases were searched for relevant articles. Results regarding TCM for SCI were identified and retrieved, then manually classified and selected for inclusion in this review.
RESULTS: The literature search identified a total of 652 articles regarding TCM for SCI. Twenty-eight treatments (16 active ingredients, nine herbs, and three compound prescriptions) were selected from these articles; the treatments have been used for the prevention and treatment of SCI. In general, these treatments involved antioxidative, anti-inflammatory, neuroprotective, and/or antiapoptotic effects of TCM compounds.
CONCLUSIONS: This paper showed that TCM treatments can serve as promising auxiliary therapies for functional recovery of patients with SCI. These findings will contribute to the development of diversified treatments for SCI.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Active ingredient; Compound prescription; Nerve repair; Spinal cord injury; Traditional Chinese medicine

Year:  2020        PMID: 32335299     DOI: 10.1016/j.biopha.2020.110136

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Protective effects of muscone on traumatic spinal cord injury in rats.

Authors:  Chao Yu; Fei Gui; Qian Huang; Yuanmeng Luo; Zili Zeng; Ruifu Li; Liang Guo
Journal:  Ann Transl Med       Date:  2022-06

2.  Knockdown of lncRNA SNHG14 alleviates LPS-induced inflammation and apoptosis of PC12 cells by regulating miR-181b-5p.

Authors:  Hui Jiang; Jie Ni; Yan Zheng; Yun Xu
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

3.  Deciphering Pharmacological Mechanism of Buyang Huanwu Decoction for Spinal Cord Injury by Network Pharmacology Approach.

Authors:  Zhencheng Xiong; Feng Yang; Wenhao Li; Xiangsheng Tang; Haoni Ma; Ping Yi
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-22       Impact factor: 2.629

4.  Calycosin Induces Gastric Cancer Cell Apoptosis via the ROS-Mediated MAPK/STAT3/NF-κB Pathway.

Authors:  Yu Zhang; Jian-Qiang Zhang; Tong Zhang; Hui Xue; Wen-Bo Zuo; Yan-Nan Li; Yue Zhao; Geng Sun; Zhong-Ren Fu; Qing Zhang; Xue Zhao; Yue Teng; An-Qi Wang; Jia-Zhu Li; Ying Wang; Cheng-Hao Jin
Journal:  Onco Targets Ther       Date:  2021-04-12       Impact factor: 4.147

5.  Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury.

Authors:  Shaoshuo Li; Yang Shao; Hao Chen; Jianwei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-27       Impact factor: 2.629

6.  Systematic Nursing Interventions Combined with Continuity of Care in Patients with a Spinal Fracture Complicated with a Spinal Cord Injury and Its Effect on Recovery and Satisfaction.

Authors:  Yingjie Xia; Jing Wang; Ping Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-05       Impact factor: 2.650

7.  Total flavonoids of hawthorn leaves protect spinal motor neurons via promotion of autophagy after spinal cord injury.

Authors:  Qiong Zhang; Mingfu Liu; Haibin Nong; Yanan Zhang; Yiguang Bai; Pan Liu; Shaohui Zong; Gaofeng Zeng
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

8.  Exploring the mechanism of Buyang Huanwu Decoction in the treatment of spinal cord injury based on network pharmacology and molecular docking.

Authors:  Ying Wang; Haixu Chen; Junwei Wang; Xin Chen; Lan Chen
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

Review 9.  Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.

Authors:  Liu-Cheng Li; Zhi-Hui Zhang; Wen-Cheng Zhou; Jie Chen; Hua-Qian Jin; Hong-Mei Fang; Qin Chen; Ye-Cheng Jin; Jiao Qu; Lian-Di Kan
Journal:  Biomed Pharmacother       Date:  2020-08-19       Impact factor: 6.529

10.  Effectiveness of electroacupuncture (EA) for the treatment of urinary incontinence (UI) in patients with spinal cord injury (SCI): A protocol of systematic review of randomized controlled trials.

Authors:  Tian-Shu Wang; Zeng-Mian Wang; Yu Zhao; Zhao-Chen Tang; Wei-Dong Song; Guan-Kai Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.